In addition, as we showed in Fig 1B and C, IDH wild-type GBMs are more hypomethylated at baseline than IDH-mutants, and thus to increase our ability to detect methylation change after remethylation, we used the more hypomethylated IDH wild-type gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.